Keyphrases
Placebo-controlled Randomized Trial
100%
Stable Coronary Artery Disease
100%
Ticagrelor
100%
Patients with Diabetes
100%
THEMIS
100%
Percutaneous Coronary Intervention
100%
Aspirin
28%
Placebo
28%
Intervention Studies
21%
Cardiovascular Mortality
21%
Major Bleeding
14%
Net Clinical Benefit
14%
Myocardial Infarction
14%
Efficacy Outcomes
14%
Coronary Artery
7%
All-cause Mortality
7%
Intention-to-treat
7%
Treatment Group
7%
AstraZeneca
7%
Coronary Artery Bypass Grafting
7%
Antihyperglycemic
7%
Non-exclusive
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Ischemic Risk
7%
Fatal Bleeding
7%
Response System
7%
Diabetes
7%
Intervention Group
7%
Intracranial Hemorrhage
7%
Placebo-controlled Trial
7%
High Risk
7%
Angiographic Stenosis
7%
Placebo Groups
7%
Diabetes Mellitus Patients
7%
Long-term Treatment
7%
Health Outcomes
7%
Antiplatelet Therapy
7%
Patient-centered Intervention
7%
Voice User Interface
7%
Ischemic Events
7%
Bleeding Risk
7%
Medicine and Dentistry
Ticagrelor
100%
Coronary Artery Disease
100%
Randomized Controlled Trial
100%
Percutaneous Coronary Intervention
100%
Placebo
100%
Patient with Diabetes
100%
Acetylsalicylic Acid
28%
Cardiovascular System
21%
Apoplexy
14%
Myocardial Infarction
14%
Major Bleeding
14%
Intervention Trial
14%
Cause of Death
7%
Coronary Artery Bypass Graft
7%
Stenting
7%
Bleeding
7%
Diabetes
7%
Stenosis
7%
Health Outcomes
7%
Diabetes Mellitus
7%
Intention-to-Treat Analysis
7%
Antiplatelet
7%
Coronary Artery
7%
Maturity Onset Diabetes of the Young
7%
Intervention Study
7%
Cerebral Hemorrhage
7%
Pharmacology, Toxicology and Pharmaceutical Science
Ticagrelor
100%
Coronary Artery Disease
100%
Randomized Controlled Trial
100%
Placebo
100%
Acetylsalicylic Acid
33%
Bleeding
25%
Intervention Trial
16%
Heart Infarction
16%
Cerebrovascular Accident
16%
Brain Hemorrhage
8%
Antiplatelet
8%
Diabetes Mellitus
8%
Stenosis
8%
Intervention Study
8%
Cause of Death
8%
Non Insulin Dependent Diabetes Mellitus
8%